{
    "accessibility": "Open access",
    "additionDate": "2024-01-30T15:38:24.761591Z",
    "biotoolsCURIE": "biotools:ab-amy",
    "biotoolsID": "ab-amy",
    "confidence_flag": "tool",
    "cost": "Free of charge",
    "credit": [
        {
            "email": "hj@uestc.edu.cn",
            "name": "Jian Huang",
            "typeEntity": "Person"
        },
        {
            "name": "Yushu Gou",
            "typeEntity": "Person"
        },
        {
            "name": "Yuwei Zhou",
            "typeEntity": "Person"
        },
        {
            "name": "Ziru Huang",
            "typeEntity": "Person"
        }
    ],
    "description": "Machine learning aided amyloidogenic risk prediction of therapeutic antibody light chains.",
    "editPermission": {
        "type": "private"
    },
    "function": [
        {
            "input": [
                {
                    "data": {
                        "term": "Protein sequence",
                        "uri": "http://edamontology.org/data_2976"
                    },
                    "format": [
                        {
                            "term": "FASTA",
                            "uri": "http://edamontology.org/format_1929"
                        },
                        {
                            "term": "raw",
                            "uri": "http://edamontology.org/format_1957"
                        }
                    ]
                }
            ],
            "operation": [
                {
                    "term": "Aggregation",
                    "uri": "http://edamontology.org/operation_3436"
                },
                {
                    "term": "Deposition",
                    "uri": "http://edamontology.org/operation_3431"
                },
                {
                    "term": "Protein architecture recognition",
                    "uri": "http://edamontology.org/operation_2475"
                }
            ]
        }
    ],
    "homepage": "http://i.uestc.edu.cn/AB-Amy/",
    "lastUpdate": "2024-01-30T15:38:24.764865Z",
    "license": "CC-BY-NC-4.0",
    "name": "AB-Amy",
    "operatingSystem": [
        "Linux",
        "Mac",
        "Windows"
    ],
    "owner": "Pub2Tools",
    "publication": [
        {
            "doi": "10.1093/ABT/TBAD007",
            "metadata": {
                "abstract": "Over 120 FDA-approved antibody-based therapeutics are used to treat a variety of diseases.However, many candidates could fail because of unfavorable physicochemical properties. Light-chain amyloidosis is one form of aggregation that can lead to severe safety risks in clinical development. Therefore, screening candidates with a less amyloidosis risk at the early stage can not only save the time and cost of antibody development but also improve the safety of antibody drugs. In this study, based on the dipeptide composition of 742 amyloidogenic and 712 non-amyloidogenic antibody light chains, a support vector machine-based model, AB-Amy, was trained to predict the light-chain amyloidogenic risk. The AUC of AB-Amy reaches 0.9651. The excellent performance of AB-Amy indicates that it can be a useful tool for the in silico evaluation of the light-chain amyloidogenic risk to ensure the safety of antibody therapeutics under clinical development. A web server is freely available at http://i.uestc.edu.cn/AB-Amy/.",
                "authors": [
                    {
                        "name": "Dzisoo A.M."
                    },
                    {
                        "name": "Gou Y."
                    },
                    {
                        "name": "Huang J."
                    },
                    {
                        "name": "Huang Z."
                    },
                    {
                        "name": "Liu S."
                    },
                    {
                        "name": "Yang W."
                    },
                    {
                        "name": "Zhang H."
                    },
                    {
                        "name": "Zhou Y."
                    }
                ],
                "date": "2023-07-01T00:00:00Z",
                "journal": "Antibody Therapeutics",
                "title": "AB-Amy: Machine learning aided amyloidogenic risk prediction of therapeutic antibody light chains"
            },
            "pmcid": "PMC10365155",
            "pmid": "37492587"
        }
    ],
    "toolType": [
        "Web application"
    ],
    "topic": [
        {
            "term": "Immunoproteins and antigens",
            "uri": "http://edamontology.org/topic_2830"
        },
        {
            "term": "Machine learning",
            "uri": "http://edamontology.org/topic_3474"
        },
        {
            "term": "Model organisms",
            "uri": "http://edamontology.org/topic_0621"
        },
        {
            "term": "Pathology",
            "uri": "http://edamontology.org/topic_0634"
        },
        {
            "term": "Safety sciences",
            "uri": "http://edamontology.org/topic_3377"
        }
    ]
}
